Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-One: One Drop | Premium with Afrezza in T2D
NCT03313960Phase 4Unknown
- Sponsor
- Informed Data Systems
- Start
- Oct 2017
- Primary completion
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of TI-Inhalation Powder B in type 2 diabetes mellitus (T2DM), sponsored by Informed Data Systems. Status: unknown.
02
Drugs
TI-Inhalation Powder B
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03313960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03313960.